Suarez, C., Choueiri, T. K., Albiges, L., Voss, M. H., McGregor, B. A., Khan, O., Williamson, D. S., Perez-Torrealba, J. R., Hall, T. D., Pal, S. K. (2025). Efficacy and safety of second-line cabozantinib ± atezolizumab for patients with advanced renal cell carcinoma after progression on immuno-oncology combinations: Subgroup analysis of CONTACT-03.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4523